Stock Market Outlook Based on Stock Market Algorithm: Returns up to 336.16% in 1 Year

Stock Market Outlook

This forecast is part of the Risk-Conscious Package, as one of I Know First’s equity research solutions. We determine our aggressive stock picks by screening our algorithm daily for higher volatility stocks that present greater opportunities but are also riskier. The full Risk-Conscious Package includes a daily stock market outlook for a total of 40 stocks divided into four main categories:

  • Top 10 Aggressive stocks for the long position
  • Top 10 Aggressive stocks for the short position
  • Top 10 Conservative stocks for the long position
  • Top 10 Conservative stocks for the short position


Package Name: Aggressive Stocks Forecast
Recommended Positions: Long
Forecast Length: 1 Year (12/2/2018 – 12/2/2019)
I Know First Average: 77.89%
Stock Market Outlook
Stock Market Outlook chart

9 out of 10 stock prices in this forecast for the Aggressive Stocks Forecast Package moved as predicted by the algorithm. ARWR was our best stock pick this week a return of 336.16%. Additional high returns came from ARRY and ACAD, at 200.38% and 140.19% respectively. The package had an overall average return of 77.89%, providing investors with a premium of 65.08% over the S&P 500’s return of 12.81% during the same period.

Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, incorporated on February 13, 2001, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, the Company’s therapies trigger the RNA interference mechanism to induce knockdown of target genes. The Company is focused on developing drugs for diseases with a genetic basis, characterized by the overproduction of one or more proteins. The Company’s preclinical pipeline of RNA interference (RNAi) therapeutics includes both subcutaneously administered liver-targeted candidates and extra-hepatic candidates. The Company’s pre-clinical-stage drug candidates include ARO-HBV, ARO-AAT, ARO-LPA, ARO-AMG1, ARO-F12 and ARO-HIF2.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.